{"id":"W4200128746","doi":"10.1038/s41591-021-01579-0","title":"Avelumab maintenance in advanced urothelial carcinoma: biomarker analysis of the phase 3 JAVELIN Bladder 100 trial","year":2021,"lang":"en","type":"article","venue":"Nature Medicine","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":115,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"Merck KGaA; Pfizer","keywords":"Javelin; Avelumab; Urothelial carcinoma; Metastatic Urothelial Carcinoma; Biomarker; Medicine; Bladder cancer; Oncology; Carcinoma; Urothelial cancer; Internal medicine; Urology; Immunotherapy; Cancer; Chemistry; Nivolumab","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001617596,0.0005180916,0.001359596,0.0002228526,0.0002200211,0.001222323,0.0004193304,0.0005587235,0.001555947],"category_scores_gemma":[0.001569532,0.0002411392,0.001384833,0.0004232555,0.0004131903,0.0008397604,0.0003269463,0.001744792,0.000328111],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006716109,"about_ca_system_score_gemma":0.0006784503,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004753857,"about_ca_topic_score_gemma":0.001531511,"domain_scores_codex":[0.9994991,0.0002618296,0.00002123349,0.00008682025,0.00005209659,0.00007893652],"domain_scores_gemma":[0.9992319,0.0002097487,0.0002399907,0.00007979694,0.00004758536,0.0001909671],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.6107697,0.005846503,0.04900737,0.001836338,0.008431952,0.0002095671,0.0002796948,0.005106779,0.04068725,0.0009053198,0.008830873,0.2680887],"study_design_scores_gemma":[0.4170421,0.2217513,0.2910909,0.0005807268,0.01199043,0.001339927,0.0003760503,0.009537062,0.01615891,0.002658222,0.02724507,0.0002293653],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9887321,0.008170722,0.0002470853,0.0006322084,0.00007816093,0.0001189487,0.0008171926,0.00005611886,0.00114744],"genre_scores_gemma":[0.993244,0.002600327,0.000601875,0.0005485226,0.00006869667,0.0001594673,0.001512593,0.00002401267,0.001240498],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001617596,"threshold_uncertainty_score":0.008554757,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02005866707782456,"score_gpt":0.3429450405668656,"score_spread":0.3228863734890411,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}